ILF2 and Miyoshi myopathy: The ILF2 ASO 1146809 (09), which elicited the best dose response and had an acceptable tolerability profile in mice was selected for functional validation studies in MM cells (Supplementary Fig. 1A, B, and Supplementary Table 1).